Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients
Cytometry Part B: Clinical Cytometry · 2025
DOI: 10.1002/cyto.b.22236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Ludivine Fourdrain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hématologie Biologique, CHU Amiens-Picardie, Amiens, France. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Melanoma, Flow Cytometry, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Melanoma is an aggressive skin tumor whose incidence is rising sharply, and for which the determination of new prognostic factors is a major challenge. In oncology, circulating tumor cells (CTCs) are at the heart of much research, as they represent a source of tumor material obtained non‐invasively by liquid biopsy. With this in mind, this prospective, longitudinal study looked at the detection of CTCs in melanoma patients using the flow cytometry technique, and constitutes a proof‐of‐principle study, as molecular biology is the most widely used technique today to detect CTCs. The labeling strategy showed high sensitivity and specificity for melanoma cells. All 35 patients in the cohort presented at least one CTC at inclusion, demonstrating that the cells circulate regardless of the stage of the disease. However, a significant increase in the number of CTCs was observed in metastatic stages compared with non‐metastatic stages. With regard to the main prognostic factors for melanoma, no significant association was found between the number of CTCs and Breslow thickness or the presence of ulceration. This study must be continued in order to increase the size of the sample, with a more consistent longitudinal follow‐up, in order to gain a better understanding of the prognostic significance of CTCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service d'Hématologie Biologique, CHU Amiens-Picardie, Amiens, France.
- Service de Dermatologie, CHU Amiens-Picardie, Amiens, France.
- Service d'Hématologie Biologique, Hôpital Saint-Louis AP-HP, Paris, France.
- HEMATIM, EA 4666, Université Picardie Jules Verne, Amiens, France.
- Laboratoire d'Immunologie, CHU Amiens-Picardie, Amiens, France.
ORCID-Profile: Thomas Boyer
Zitieren
APA
Fourdrain, L., Brochet, T., Clichet, V., Chaby, G., Gubler, B., Garçon, L., Arnault, J. P., & Boyer, T. (2025). Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22236
Vancouver
Fourdrain L, Brochet T, Clichet V, Chaby G, Gubler B, Garçon L, et al. Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22236
BibTeX
@article{Fourdrain2025,
author = {Fourdrain, Ludivine and Brochet, Théo and Clichet, Valentin and Chaby, Guillaume and Gubler, Brigitte and Garçon, Loïc and Arnault, Jean-Philippe and Boyer, Thomas},
title = {Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2025},
doi = {10.1002/cyto.b.22236}
}
EUVIMED